DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Krop IE et al.
Trastuzumab emtansine versus treatment of physician’s choice for pretreated HER2-positive advanced breast cancer (THERESA): a randomised, open-label, phase 3 trial.
Lancet Oncol 2014;
15(7): 689-99
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.